Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BI 853520 + Garsorasib |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BI 853520 | ifebemtinib|IN10018|IN 10018|IN-10018|BI853520|BI-853520 | FAK inhibitor 16 | BI 853520 inhibits PTK2 (FAK), which may result in tumor growth inhibition (Mol Cancer Ther November 2011 10; A249, PMID: 30756308). | |
| Garsorasib | D1553|D 1553|D-1553 | KRAS G12C inhibitor 36 | Garsorasib (D-1553) inhibits KRAS G12C, which potentially results in decreased tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr 932, PMID: 36948246). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|